Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07127510

Brain NAD in Alzheimer's Disease

Sponsor: Florida Atlantic University

View on ClinicalTrials.gov

Summary

The goal of this observational study is to learn about the levels of nicotinamide adenine dinucleotide (NAD) in the brains of people with Alzheimer's disease. The study aims to determine if brain NAD levels are lower in people with Alzheimer's disease compared with people of the same age group who do not have Alzheimer's disease. Participants with or without Alzheimer's disease will have a brain imaging session where NAD will be measured using magnetic resonance spectroscopy (MRS). Eight months later, they will have a second, similar, brain imaging session.

Official title: Measurement of Brain NAD Levels in Alzheimer's Patients and Control Subjects by 1H-MRS

Key Details

Gender

All

Age Range

65 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

20

Start Date

2026-03-18

Completion Date

2027-06-01

Last Updated

2026-03-24

Healthy Volunteers

Yes

Locations (1)

FAU Clinical Research Unit

Boca Raton, Florida, United States